Excluding non-melanoma skin cancer and contralateral breast cancer, carriers of deleterious variants in BRCA1 or BRCA2 did not have a statistically significant difference in personal history of other cancers (20% vs. 24.6%, p = 0.77) or mean age at diagnosis of breast cancer (60.4 vs. 61.2 years, p = 0.81) compared to non-carriers. This evidence concerns the gene BRCA1 and breast carcinoma.